Skip to main content

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

Premi a la trajectòria investigadora als Hospitals de l'ICS

IP: Rafael Simó Canonge
Collaborators: -
Funding agency: Institut Català de la Salut
Funding: 5000
Reference: ICS/TRAJECTORIA.HOSP/2021/SIMÓ
Duration: 28/06/2021 - 28/06/2021

Beques de Formació de Personal Investigador (FPI) Identificación de los mediadores comunes a la neurodegeneracion inducida por la diabetes en retina y cerebro / Unraveling the common mediators of retinal and brain diabetes-induced neurodegeneration (U

IP: Rafael Simó Canonge
Collaborators: Beques de Formació de Personal Investigador (FPI) Identificación de los mediadores comunes a la neurodegeneracion inducida po, Miriam Izquierdo Sans
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 98960
Reference: PRE2020-095747
Duration: 01/09/2021 - 30/08/2025

Ministerio de Ciencia

Estudio de seguridad y eficacia de la sitagliptina en colirio para el tratamiento de los estadios iniciales de retinopatía diabética.

IP: Rafael Simó Canonge
Collaborators: Marc Rivas Agudo, Cristina Hernández Pascual, José García Arumí
Funding agency: Instituto de Salud Carlos III
Funding: 573650
Reference: ICI20/00129
Duration: 01/01/2021 - 31/10/2026

H2O Health Outcomes Observatory

IP: Yolima Cossio Gil
Collaborators: Cristina Hernández Pascual, Natalia Borruel Sainz, Gemma Galán Martinez, Monica Sanchez Bartres, Marta Ferri Peradalta, Rafael Simó Canonge, Joan Carles Peiró Ruiz
Funding agency: The Innovative Medicines Initiative
Funding: 1097257.5
Reference: H2O_IMI2-2020
Duration: 01/10/2020 - 30/09/2025

Related news

The grants, amounting to more than €533,000 for VHIR, will allow clinical duties to be partially released over three years to promote strategic research projects in obesity, respiratory diseases, aortic pathology and metabolic fatty liver disease.

The study will validate the safety of a novel topical ocular administration route for sitagliptin.

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research

Related professionals

Figuera Segarra, Nuria

Figuera Segarra, Nuria

Multidisciplinary Nursing Research Group
Read more
Sala Coromina, Julia

Sala Coromina, Julia

Research technician
Pediatric Neurology
Read more
Espinosa Lopez, Blanca

Espinosa Lopez, Blanca

Predoctoral researcher
Childhood Cancer and Blood Disorders
Read more
Camblor Blasco, Andrea

Camblor Blasco, Andrea

Predoctoral researcher
Cardiovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.